Clinical Trials Logo

Clinical Trial Summary

Incisional hernia is one of the most common complications of abdominal surgery and carries a significant burden for both patients and the economic health service. However, no consensus for the surgical treatment of incisional hernia in contaminated field is currently available. The purpose of the COMpACT-BIO study is to investigate the clinical and economic benefit of the use of biosynthetic mesh in contaminated incisional hernia repair.


Clinical Trial Description

The current standard of incisional hernia repair is reinforcement with permanent synthetic mesh. However, permanent synthetic mesh is contraindicated in contaminated surgical field due to higher risk of postoperative infection. In order to resist to infection, absorbable meshes, such as biological and biosynthetic meshes, have been developped. However, some controversies exist about the clinical benefit of biological meshes in the long term. Reasons for theses controversies are their overall risk of complication and recurrence and the lack of consensus in which surgical technique to apply. Moreover, the financial cost of biological meshes is very high. Recently developed, biosynthetic meshes appear to be a promising option ; Compared to biological meshes, they seem to have several advantages. However, such data demonstrating the beneficial use of biosynthetic mesh in contaminated incisional hernia repair is not available. In this regard, the COMpACT-BIO study aims to investigate the clinical and economic benefit of the use of biosynthetic mesh in contaminated incisional hernia repair in comparison to the standard of repair. This is a multicenter, prospective, longitudinal and randomized study, which also offers a standardized technique of repair. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04597840
Study type Interventional
Source Hospices Civils de Lyon
Contact Guillaume PASSOT, Pr
Phone 4 78 86 23 71
Email guillaume.passot@chu-lyon.fr
Status Recruiting
Phase N/A
Start date May 25, 2021
Completion date October 2024

See also
  Status Clinical Trial Phase
Terminated NCT01981044 - SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair N/A
Completed NCT03945357 - Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial) Phase 3
Suspended NCT02505204 - PVB With vs. Without Clonidine for Ventral Hernia Repair N/A
Recruiting NCT04132986 - Study of Absorbable Biosynthetic Meshes in Contaminated Ventral Hernia Repair